New app boosts chemo knowledge for nurses, study finds
NCT ID NCT06976450
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 40 times
Summary
This study tested a mobile app called ChemoNurs, designed to help oncology nurses learn about chemotherapy drugs. Fifty-nine nurses from a Turkish hospital used the app, and researchers measured changes in their knowledge and attitudes. The results showed that the app improved nurses' understanding of chemotherapy and promoted more positive attitudes toward their work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hacettepe University Oncology Hospital
Ankara, Altındağ, 06230, Turkey (Türkiye)
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ChemoNurs mobile application
What this could lead to
If effective, this app could become a standard tool to help oncology nurses quickly learn about chemotherapy drugs, improving patient safety and care.
What could go wrong
This was a small, single-center study with only 59 nurses. Results may not apply to other hospitals or countries, and the app's long-term impact on patient outcomes is unknown.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.